A deal between Swedish biotech firm Ellen AB and Chinese company Beijing Zhonglian Pharmaceutical saw shares in the Scandinavian company soar last week on the back of an announcement to distribute probiotic tampons “bathed in human lactic acid bacteria” in the Asian country. Read the full story






